HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma.

ABSTRACT:

Background

Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers, worldwide. Considering the role of human papilloma virus (HPV) in tumor development and sensitivity to treatment of HNSCC, we aimed to explore the prognostic classification ability of HPV-related signatures in head and neck cancer.

Methods

HPV-related signatures were screened out based on Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) databases. HPV-related signatures with prognostic value were identified through univariate Cox regression analysis and a risk signature was established by least absolute shrinkage and selection operator (LASSO). Further, we developed a nomogram by integrating independent prognostic factors.

Results

A total of 55 HPV-associated signatures were differentially expressed and ten of them were associated with prognosis of HNSCC patients. The prognostic signature based on CDKN2A, CELSR3, DMRTA2, SERPINE1, TJP3, FADD, and IGF2BP2 expression was constructed. Univariate and multivariate regression analyses demonstrated that the novel prognostic signature was an independent prognostic factor of HNSCC. The nomogram integrating the prognostic signature and other independent prognostic factors was developed.

Conclusion

In summary, the prognostic signature of the HPV-related signatures might serve as an important prognostic biomarker for patients with HNSCC.

SUBMITTER: Zhao H 

PROVIDER: S-EPMC9681561 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature